Enterovirulent E. coli in inflammatory and noninflammatory bowel diseases

K Čurová, M Kmeťová, M Sabol, L Gombošová… - Folia microbiologica, 2009 - Springer
We determined the incidence of enterovirulent E. coli (EVEC; which can to cause
gastrointestinal infections) in strains isolated from patients with both of the major …

癌胚抗原相关黏附分子6 促进肿瘤的发生, 发展

臧明德, 刘炳亚, 燕敏 - 外科理论与实践, 2014 - qk.sjtu.edu.cn
癌胚抗原相关黏附分子6 (carcinoembryonic antigenrelated cell adhesion molecule 6,
CEACAM6), 属于免疫球蛋白超家族, 在多种实体肿瘤中高表达, 对肿瘤的发生 …

[HTML][HTML] 炎症性肠病与免疫学关系研究进展

施华秀, 任建林, 董卫国 - 世界华人消化杂志, 2008 - wjgnet.com
炎症性肠病是一组病因未明的慢性肠道炎症性疾病, 其临床症状以腹痛和腹泻为主,
病因和发病机制错综复杂, 包括多种因素, 其中与机体免疫系统关系密切, 目前研究发现免疫异常 …

[引用][C] 炎症性肠病的发病机制研究进展

周成会, 刘纯伦 - 重庆医学, 2009

[引用][C] TNF-α 在IBD 发病机制中的调节

郑海涵, 吴正祥 - 胃肠病学和肝病学杂志, 2011

Pediatric surgery and the human microbiome

EM Carlisle, MJ Morowitz - Journal of pediatric surgery, 2011 - Elsevier
Bold advances in the past decade have made it possible to carefully study the contributions
of microbes to normal human development and to disease pathogenesis. The intestinal …

[引用][C] 中国炎症性肠病的诊断

吴开春 - 中华消化杂志, 2008

Роль дефектов аутофагии и значение адгезивно-инвазивных Escherichia coli в генезе болезни Крона

ИВ Маев, ДН Андреев, ДВ Ракитина… - Российский журнал …, 2015 - gastro-j.ru
Аннотация Цель обзора. Представить новые данные о роли молекулярно-
генетических нарушений врожденного иммунитета при болезни Крона (БК), а также …

Role of Rifaximin in inflammatory bowel disease treatment

M Lia Scribano - Mini Reviews in Medicinal Chemistry, 2016 - ingentaconnect.com
Inflammatory bowel diseases are characterised by an altered composition of the intestinal
microbiota, which may contribute to their development and maintenance in susceptible …

[引用][C] 高原地区炎症性肠病124 例调查分析

邢征, 张根苗, 金志, 焦燕 - 临床消化病杂志, 2009